Medicine
Olopatadine 665 mcg nasal spray
Olopatadine 665 mcg nasal spray is a generic prescription medicine for nasal use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store olopatadine HCl nasal spray at room temperature between 4°C to 25°C…
Key facts
- Active ingredient (INN)
- Olopatadine
- Brand
- Sold under the generic name
- Strength
- 665 mcg
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 1 bottle and 2 more
- Manufacturers
- Bryant Ranch PrepackAmneal PharmaceuticalsApotexPadagis Israel Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store olopatadine HCl nasal spray at room temperature between 4°C to 25°C (39°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R01AC08 Olopatadine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 October 2014
- Identifiers
- RxCUI 1797895DailyMed set ID 806e8d0f-ff42-4d6e-b840-49e3bf867cb5, 3aa27224-7b72-38eb-0c21-b8d73525ee85, db024b9c-681f-4503-9fda-1eaa1add4746 +2NDC 65162-890, 60505-0845, 72162-1390 +2Application ANDA210901, ANDA091572, ANDA202853
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, spray in 1 carton / 665 spray, metered in 1 bottle, spray | 65162-890-23 | Amneal Pharmaceuticals | 3 February 2020 |
| 1 bottle in 1 carton / 240 spray, metered in 1 bottle | 60505-0845-5 | Apotex | 27 October 2014 |
| 1 bottle in 1 carton / 240 spray in 1 bottle | 45802-104-01 | Padagis Israel Pharmaceuticals | 14 June 2017 |
| 1 bottle in 1 carton / 240 spray in 1 bottle | 63629-8434-1 | Bryant Ranch Prepack | 28 April 2021 |
| 1 bottle in 1 carton / 240 spray in 1 bottle | 72162-1390-2 | Bryant Ranch Prepack | 29 August 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Olopatadine
Clinical summary
Olopatadine is a histamine-1 receptor inhibitor indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 years of age and older. MedsAcross supplies Olopatadine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OlopatadineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Olopatadine Hydrochloride prescribing information (Apotex) · U.S. National Library of Medicine, DailyMed
- Opatanol: European public assessment report (EPAR) · European Medicines Agency
Need Olopatadine 665 mcg nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.